Previous Close | 79.31 |
1-Year Change | 175.86% |
6-Months Change | 4.08% |
3-Months Change | 19.07% |
Moving Avg (50d) | 73.79 |
Moving Avg (200d) | 67.364 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 11.3B |
Beta (3-Years) | 1.11 |
Revenue Growth (ttm) | 15.95% |
Net Profit Margin (ttm) | -257.69% |
Return On Assets (ttm) | -54.62% |
EPS (ttm) | -5.29 |
PE Ratio (ttm) | -14.99 |
Dividend Yield | % |
Asset Description: | Insmed Incorporated |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2025-02-10 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
80.896 | 83.275 | 84.862 | 87.241 | 91.206 | 95.172 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |